Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -41.50
- Piotroski Score 4.00
- Grade Buy
- Symbol (BTCY)
- Company Biotricity, Inc.
- Price $0.32
- Changes Percentage (12.43%)
- Change $0.04
- Day Low $0.27
- Day High $0.32
- Year High $1.67
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/18/2025
- Fiscal Year End N/A
- Average Stock Price Target $4.00
- High Stock Price Target $4.00
- Low Stock Price Target $4.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.75
- Trailing P/E Ratio -0.62
- Forward P/E Ratio -0.62
- P/E Growth -0.62
- Net Income $-14,094,283
Income Statement
Quarterly
Annual
Latest News of BTCY
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Biotricity Inc (BTCY) Q2 2025 Earnings Call Highlights: Milestone Achievements and Strategic Growth
The CEO discusses how the cardiac AI cloud focuses on early detection of arrhythmias, improving patient outcomes and operational efficiencies. SG&A reductions come from economies of scale, optimized m...
By Yahoo! Finance | 1 week ago
